Dietary niacin, an essential nutrient, protects against metabolic diseases; however, its association with Cardiovascular-Kidney-Metabolic (CKM) syndrome and related mortality remains poorly understood. We examined the associations between dietary niacin intake and the prevalence of advanced CKM syndrome using logistic regression models, as well as the associations between dietary niacin intake and mortality (all-cause, cardiovascular, and cancer) across CKM stages using Cox proportional hazards models, based on data from the National Health and Nutrition Examination Survey. Non-linear relationships were examined using restricted cubic spline (RCS) analyses. Among the 14,282 participants, 14.3% (2,042/14,282) were identified as having advanced-stage CKM syndrome. Higher dietary niacin intake was inversely associated with the prevalence of advanced-stage CKM syndrome (odds ratio [OR] = 0.72, 95% CI: 0.62-0.85). Stronger inverse associations were observed among participants aged over 40 years, those with higher physical activity levels, and those without hyperlipidemia. In patients with CKM stages 0-2, higher niacin intake was inversely associated with the risks of all-cause mortality (hazard ratio [HR] 0.75, 95% CI: 0.61-0.91), cardiovascular mortality (HR 0.53, 95% CI: 0.29-0.94), and cancer mortality (HR 0.70, 95% CI: 0.49-0.93). In patients with CKM stages 3-4, higher niacin intake was negatively associated with the risks of all-cause mortality (HR 0.82, 95% CI: 0.67-0.97) and cancer mortality (HR 0.53, 95% CI: 0.29-0.95). RCS analysis revealed a negative linear relationship of dietary niacin with advanced CKM syndrome and non-linear associations with all-cause, cardiovascular, and cancer mortality among patients in CKM stages 3-4. Dietary niacin intake may be associated with a lower prevalence of advanced-stage CKM syndrome and reduced mortality across all CKM stages, suggesting its potential role in dietary interventions for CKM prevention and management.